Clinical Trial Update: SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)

View source ↗

Summary

The clinical trial SMASH is evaluating an extensively hydrolyzed infant formula with synbiotics and a human milk oligosaccharide (HMO) for infants with cow's mi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cow Milk Protein Allergy
• Food Hypersensitivity

Snippet

Sponsor: Outcomes'10 | Conditions: Cow's Milk Protein Allergy (CMPA), Food Hypersensitivity | Status: RECRUITING